I was delighted to catch up with Cherwell Laboratories MD Andy Whittard as part of this years #RefelectionsandForecasts interview series.
We talked about Cherwell Laboratories, their achievements in 2022, their "Delivery Knowledge" platform, meeting the challenges in 2022, the impact of #Annex1 on #EnviromentalMonitoring, #ContinuousMonitoring, #supplychain, co-operation, and sustainability.
2022 Reflections
• Can you give me a quick overview of Cherwell Laboratories? 00:39
• One word to describe 2022 and why? 01;50
• What were some of Cherwell Laboratories key achievements in 2022? 04:40
• Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 05:29
• How have Cherwell managed customers expectations due to the challenges around Supply Chain issues? 08:03
• Did Andy think that dealing with the Covid19 period helped the business become more "agile"? 09:33
• When Annex 1 came out in August was it what Andy expected it to be? 11:33
• Are there any areas you think the industry could improve? 13:13
2023 Forecasts
• What are your predictions for the Life Science/Pharma/ BioPharma in 2023? 15:14
• What developments and trends do you expect to see/predict in contamination control with the new Annex One Updates? 17:49
• Where does Andy think AI and Machine learning can help in Environmental Monitoring?24:14
• What can we expect from Cherwell Laboratories 2023? 25:52
• Finally, what last thoughts would you like to leave viewers with for 2023? 29:09
You can check out #Cherwells online EU #GMP and #Annex resources page which provides further background and insight on the latest regulatory update governing the manufacture of #sterile #medicinalproducts, at https://lnkd.in/geW5f2EV
and learn more about Cherwell Laboratories at www.cherwell-labs.co.uk
You can WATCH the interview here https://lnkd.in/ecsqJjK6
